Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valeria Onnis

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Future Medicinal Chemistry|March 24, 2011
Rational ligand-based virtual screening and structure-activity relationship studies in the ligand-binding domain of the glucocorticoid receptor-αValeria Onnis, Gemma K Kinsella, Giorgio Carta, et al.
Future Medicinal Chemistry|March 24, 2011
Rational structure-based drug design and optimization in the ligand-binding domain of the glucocorticoid receptor-αValeria Onnis, Gemma K Kinsella, Giorgio Carta, et al.
Journal of Computer-Aided Molecular Design|July 15, 2006
Permuting input for more effective sampling of 3D conformer spaceGiorgio Carta, Valeria Onnis, Andrew J S Knox, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 5, 2007
STI-571 (imatinib mesylate) enhances the apoptotic efficacy of pyrrolo-1,5-benzoxazepine-6, a novel microtubule-targeting agent, in both STI-571-sensitive and -resistant Bcr-Abl-positive human chronic myeloid leukemia cellsLisa M Greene, Liam Kelly, Valeria Onnis, et al.
Journal of Medicinal Chemistry|March 26, 2010
Virtual screening for the identification of novel nonsteroidal glucocorticoid modulatorsValeria Onnis, Gemma K Kinsella, Giorgio Carta, et al.
Molecular Pharmacology|March 31, 2006
Identification of tubulin as the molecular target of proapoptotic pyrrolo-1,5-benzoxazepinesJude M Mulligan, Lisa M Greene, Suzanne Cloonan, et al.
Vaccine|April 27, 2022
Clinically proven specification setting for a meningococcal serogroup a conjugate vaccineValeria Onnis, Alessio Moriconi, Marilena Paludi, et al.
ACS Omega|November 17, 2022
Development of a New Solid-Phase Extraction Base Method for Free Saccharide Content Estimation of Meningococcal Conjugate VaccinesRiccardo De Ricco, Francesca Rech, Valeria Onnis, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Future Medicinal Chemistry|March 24, 2011
Rational ligand-based virtual screening and structure-activity relationship studies in the ligand-binding domain of the glucocorticoid receptor-αValeria Onnis, Gemma K Kinsella, Giorgio Carta, et al.
Future Medicinal Chemistry|March 24, 2011
Rational structure-based drug design and optimization in the ligand-binding domain of the glucocorticoid receptor-αValeria Onnis, Gemma K Kinsella, Giorgio Carta, et al.
Journal of Computer-Aided Molecular Design|July 15, 2006
Permuting input for more effective sampling of 3D conformer spaceGiorgio Carta, Valeria Onnis, Andrew J S Knox, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 5, 2007
STI-571 (imatinib mesylate) enhances the apoptotic efficacy of pyrrolo-1,5-benzoxazepine-6, a novel microtubule-targeting agent, in both STI-571-sensitive and -resistant Bcr-Abl-positive human chronic myeloid leukemia cellsLisa M Greene, Liam Kelly, Valeria Onnis, et al.
Journal of Medicinal Chemistry|March 26, 2010
Virtual screening for the identification of novel nonsteroidal glucocorticoid modulatorsValeria Onnis, Gemma K Kinsella, Giorgio Carta, et al.
Molecular Pharmacology|March 31, 2006
Identification of tubulin as the molecular target of proapoptotic pyrrolo-1,5-benzoxazepinesJude M Mulligan, Lisa M Greene, Suzanne Cloonan, et al.
Vaccine|April 27, 2022
Clinically proven specification setting for a meningococcal serogroup a conjugate vaccineValeria Onnis, Alessio Moriconi, Marilena Paludi, et al.
ACS Omega|November 17, 2022
Development of a New Solid-Phase Extraction Base Method for Free Saccharide Content Estimation of Meningococcal Conjugate VaccinesRiccardo De Ricco, Francesca Rech, Valeria Onnis, et al.
Pageof 1